BrainStorm Cell Therapeutics

Research news about clinical trials testing a Parkinson’s drug and stem cells in ALS reported at the 65th annual meeting of the American Academy of Neurology

Posted on Friday, March 22, 2013 - 16:45, By: Amy Madsen
Update (July 30, 2013): BrainStorm Cell Therapeutics announced in a July 29, 2013, press release that the European Commission has granted Orphan Drug Designation to the company’s NurOwn stem cell therapy for the treatment of ALS.

A look at two stem cell studies in mice, one involving repeat doses of NurOwn stem cell therapy, and the other neural stem cell transplantation

Posted on Friday, January 25, 2013 - 10:29, By: Amy Madsen
Development of stem cell therapy to treat amyotrophic lateral sclerosis (ALS) continued with two studies in mice, one by an Israeli biotech company and one by an Italian research team.